Cambridge Investment Research Advisors, Inc. Compugen LTD Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.4 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 27, 2020
SELL
$6.97 - $17.12 $76,495 - $187,892
-10,975 Closed
0 $0
Q1 2020

May 08, 2020
BUY
$5.79 - $11.83 $63,545 - $129,834
10,975 New
10,975 $79,000
Q1 2018

May 09, 2018
SELL
$2.5 - $4.45 $28,937 - $51,508
-11,575 Closed
0 $0
Q4 2017

Feb 22, 2018
SELL
$2.35 - $4.0 $4,700 - $8,000
-2,000 Reduced 14.73%
11,575 $0
Q3 2017

Nov 07, 2017
SELL
$2.75 - $3.95 $24,530 - $35,234
-8,920 Reduced 39.65%
13,575 $52,000
Q2 2017

Aug 08, 2017
BUY
N/A
22,495
22,495 $85,000

Others Institutions Holding CGEN

# of Institutions
73
Shares Held
13.1M
Call Options Held
79.2K
Put Options Held
12.7K
View Full List

About COMPUGEN LTD

CGEN Quotes by TradingView
  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $131M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email